Table 6 A comparative analysis of sensitivity, specificity, and AUC between WHCA with and without beta-blockers
|  | 1.5 T WHCA with beta-blocker (N = 7 studies) | 1.5 T WHCA without beta-blocker (N = 15 studies) | P-value |
|---|---|---|---|
Patient-based analysis | |||
 Sensitivity | 0.91 (0.81–0.96) | 0.84 (0.78–0.89) | 0.14 |
 Specificity | 0.69 (0.57–0.78) | 0.75 (0.65–0.83) | 0.39 |
 AUC | 0.89 | 0.87 | N/A |
Vessel-based analysis | |||
 Sensitivity | 0.85 (0.77–0.91) | 0.83 (0.75–0.89) | 0.69 |
 Specificity | 0.82 (0.70–0.89) | 0.85 (0.75–0.91) | 0.63 |
 AUC | 0.89 | 0.9 | N/A |
Segment-based analysis | |||
 Sensitivity | 0.84 (0.77–0.89) | 0.78 (0.66–0.87) | 0.33 |
 Specificity | 0.91 (0.83–0.95) | 0.93 (0.87–0.96) | 0.6 |
 AUC | 0.9 | 0.93 | N/A |